Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
Submitted by
admin
on January 7, 2010 - 10:18am
Source:
BNET Pharma
News Tags:
Biogen Idec
James Mullen
Headline:
CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
Do Not Allow Advertisers to Use My Personal information
